J UROLOGY 润色咨询

JOURNAL OF UROLOGY

出版年份:1917 年文章数:6868 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:9.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1219534, encodeId=ef4712195345a, content=请问目前这个杂志需要版面费吗,投稿系统有这个板块, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d998163371, createdName=ms8000000627546001, createdTime=Sat May 14 10:42:17 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189708, encodeId=76e51189e084d, content=想问一下分子生物学实验的前列腺癌文章可以投稿么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44845159150, createdName=146b1ae0m26暂无昵称, createdTime=Wed Feb 02 14:32:40 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094379, encodeId=367010943e9c2, content=是否需要在讨论中说明文章局限性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094380, encodeId=42381094380c6, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590604, encodeId=a6fd59060405, content=with editor10天了怎么回事?第六天还更新了下状态时间下但是状态没变,是换了编辑?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573317, encodeId=b1cc5e3317e4, content=一个编辑直接拒,一个回了点comments,没啥建设性意见。都挺快的,review那个三个星期<span class="quote">yzu_mawenliang 2019-06-12 发表::<br>大概review了多久?审稿意见给了多少?</span><span class="quote">yzu_mawenliang 2019-06-12 00:00:00 发表:<br>大概review了多久?审稿意见给了多少?</span>, beContent=yzu_mawenliang 2019-06-12 发表:: 大概review了多久?审稿意见给了多少?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=384a2301707, createdName=acopolis, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583014, encodeId=d1d158301454, content=怎么样了<span class="quote">1550614717 2019-12-06 发表::<br>审稿时间:约2个月 投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。</span><span class="quote">1550614717 2019-12-06 22:14:00 发表:<br>投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。</span>, beContent=1550614717 2019-12-06 发表:: 审稿时间:约2个月 投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590835, encodeId=b01f59083538, content=请问一下,这是直接收泌尿外科相关文章的杂志吗<span class="quote">cweimed 2014-03-02 12:47:00 发表:<br>对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!</span>, beContent=cweimed 2014-03-02 12:47:00 发表: 对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590837, encodeId=291659083e9b, content=请问肾内科方向的可以投吗<span class="quote">cweimed 2014-03-02 12:47:00 发表:<br>对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!</span>, beContent=cweimed 2014-03-02 12:47:00 发表: 对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590836, encodeId=a16b590836c2, content=肾内科方向的可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2022-05-14 ms8000000627546001

    请问目前这个杂志需要版面费吗,投稿系统有这个板块

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1219534, encodeId=ef4712195345a, content=请问目前这个杂志需要版面费吗,投稿系统有这个板块, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d998163371, createdName=ms8000000627546001, createdTime=Sat May 14 10:42:17 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189708, encodeId=76e51189e084d, content=想问一下分子生物学实验的前列腺癌文章可以投稿么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44845159150, createdName=146b1ae0m26暂无昵称, createdTime=Wed Feb 02 14:32:40 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094379, encodeId=367010943e9c2, content=是否需要在讨论中说明文章局限性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094380, encodeId=42381094380c6, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590604, encodeId=a6fd59060405, content=with editor10天了怎么回事?第六天还更新了下状态时间下但是状态没变,是换了编辑?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573317, encodeId=b1cc5e3317e4, content=一个编辑直接拒,一个回了点comments,没啥建设性意见。都挺快的,review那个三个星期<span class="quote">yzu_mawenliang 2019-06-12 发表::<br>大概review了多久?审稿意见给了多少?</span><span class="quote">yzu_mawenliang 2019-06-12 00:00:00 发表:<br>大概review了多久?审稿意见给了多少?</span>, beContent=yzu_mawenliang 2019-06-12 发表:: 大概review了多久?审稿意见给了多少?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=384a2301707, createdName=acopolis, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583014, encodeId=d1d158301454, content=怎么样了<span class="quote">1550614717 2019-12-06 发表::<br>审稿时间:约2个月 投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。</span><span class="quote">1550614717 2019-12-06 22:14:00 发表:<br>投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。</span>, beContent=1550614717 2019-12-06 发表:: 审稿时间:约2个月 投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590835, encodeId=b01f59083538, content=请问一下,这是直接收泌尿外科相关文章的杂志吗<span class="quote">cweimed 2014-03-02 12:47:00 发表:<br>对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!</span>, beContent=cweimed 2014-03-02 12:47:00 发表: 对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590837, encodeId=291659083e9b, content=请问肾内科方向的可以投吗<span class="quote">cweimed 2014-03-02 12:47:00 发表:<br>对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!</span>, beContent=cweimed 2014-03-02 12:47:00 发表: 对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590836, encodeId=a16b590836c2, content=肾内科方向的可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2022-02-02 146b1ae0m26暂无昵称

    想问一下分子生物学实验的前列腺癌文章可以投稿么

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1219534, encodeId=ef4712195345a, content=请问目前这个杂志需要版面费吗,投稿系统有这个板块, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d998163371, createdName=ms8000000627546001, createdTime=Sat May 14 10:42:17 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189708, encodeId=76e51189e084d, content=想问一下分子生物学实验的前列腺癌文章可以投稿么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44845159150, createdName=146b1ae0m26暂无昵称, createdTime=Wed Feb 02 14:32:40 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094379, encodeId=367010943e9c2, content=是否需要在讨论中说明文章局限性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094380, encodeId=42381094380c6, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590604, encodeId=a6fd59060405, content=with editor10天了怎么回事?第六天还更新了下状态时间下但是状态没变,是换了编辑?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573317, encodeId=b1cc5e3317e4, content=一个编辑直接拒,一个回了点comments,没啥建设性意见。都挺快的,review那个三个星期<span class="quote">yzu_mawenliang 2019-06-12 发表::<br>大概review了多久?审稿意见给了多少?</span><span class="quote">yzu_mawenliang 2019-06-12 00:00:00 发表:<br>大概review了多久?审稿意见给了多少?</span>, beContent=yzu_mawenliang 2019-06-12 发表:: 大概review了多久?审稿意见给了多少?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=384a2301707, createdName=acopolis, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583014, encodeId=d1d158301454, content=怎么样了<span class="quote">1550614717 2019-12-06 发表::<br>审稿时间:约2个月 投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。</span><span class="quote">1550614717 2019-12-06 22:14:00 发表:<br>投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。</span>, beContent=1550614717 2019-12-06 发表:: 审稿时间:约2个月 投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590835, encodeId=b01f59083538, content=请问一下,这是直接收泌尿外科相关文章的杂志吗<span class="quote">cweimed 2014-03-02 12:47:00 发表:<br>对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!</span>, beContent=cweimed 2014-03-02 12:47:00 发表: 对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590837, encodeId=291659083e9b, content=请问肾内科方向的可以投吗<span class="quote">cweimed 2014-03-02 12:47:00 发表:<br>对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!</span>, beContent=cweimed 2014-03-02 12:47:00 发表: 对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590836, encodeId=a16b590836c2, content=肾内科方向的可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2021-12-28 Gym璨烨

    是否需要在讨论中说明文章局限性?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1219534, encodeId=ef4712195345a, content=请问目前这个杂志需要版面费吗,投稿系统有这个板块, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d998163371, createdName=ms8000000627546001, createdTime=Sat May 14 10:42:17 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189708, encodeId=76e51189e084d, content=想问一下分子生物学实验的前列腺癌文章可以投稿么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44845159150, createdName=146b1ae0m26暂无昵称, createdTime=Wed Feb 02 14:32:40 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094379, encodeId=367010943e9c2, content=是否需要在讨论中说明文章局限性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094380, encodeId=42381094380c6, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590604, encodeId=a6fd59060405, content=with editor10天了怎么回事?第六天还更新了下状态时间下但是状态没变,是换了编辑?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573317, encodeId=b1cc5e3317e4, content=一个编辑直接拒,一个回了点comments,没啥建设性意见。都挺快的,review那个三个星期<span class="quote">yzu_mawenliang 2019-06-12 发表::<br>大概review了多久?审稿意见给了多少?</span><span class="quote">yzu_mawenliang 2019-06-12 00:00:00 发表:<br>大概review了多久?审稿意见给了多少?</span>, beContent=yzu_mawenliang 2019-06-12 发表:: 大概review了多久?审稿意见给了多少?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=384a2301707, createdName=acopolis, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583014, encodeId=d1d158301454, content=怎么样了<span class="quote">1550614717 2019-12-06 发表::<br>审稿时间:约2个月 投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。</span><span class="quote">1550614717 2019-12-06 22:14:00 发表:<br>投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。</span>, beContent=1550614717 2019-12-06 发表:: 审稿时间:约2个月 投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590835, encodeId=b01f59083538, content=请问一下,这是直接收泌尿外科相关文章的杂志吗<span class="quote">cweimed 2014-03-02 12:47:00 发表:<br>对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!</span>, beContent=cweimed 2014-03-02 12:47:00 发表: 对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590837, encodeId=291659083e9b, content=请问肾内科方向的可以投吗<span class="quote">cweimed 2014-03-02 12:47:00 发表:<br>对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!</span>, beContent=cweimed 2014-03-02 12:47:00 发表: 对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590836, encodeId=a16b590836c2, content=肾内科方向的可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2021-12-27 Gym璨烨

    讨论中局限性怎么撰写?

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1219534, encodeId=ef4712195345a, content=请问目前这个杂志需要版面费吗,投稿系统有这个板块, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d998163371, createdName=ms8000000627546001, createdTime=Sat May 14 10:42:17 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189708, encodeId=76e51189e084d, content=想问一下分子生物学实验的前列腺癌文章可以投稿么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44845159150, createdName=146b1ae0m26暂无昵称, createdTime=Wed Feb 02 14:32:40 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094379, encodeId=367010943e9c2, content=是否需要在讨论中说明文章局限性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094380, encodeId=42381094380c6, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590604, encodeId=a6fd59060405, content=with editor10天了怎么回事?第六天还更新了下状态时间下但是状态没变,是换了编辑?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573317, encodeId=b1cc5e3317e4, content=一个编辑直接拒,一个回了点comments,没啥建设性意见。都挺快的,review那个三个星期<span class="quote">yzu_mawenliang 2019-06-12 发表::<br>大概review了多久?审稿意见给了多少?</span><span class="quote">yzu_mawenliang 2019-06-12 00:00:00 发表:<br>大概review了多久?审稿意见给了多少?</span>, beContent=yzu_mawenliang 2019-06-12 发表:: 大概review了多久?审稿意见给了多少?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=384a2301707, createdName=acopolis, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583014, encodeId=d1d158301454, content=怎么样了<span class="quote">1550614717 2019-12-06 发表::<br>审稿时间:约2个月 投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。</span><span class="quote">1550614717 2019-12-06 22:14:00 发表:<br>投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。</span>, beContent=1550614717 2019-12-06 发表:: 审稿时间:约2个月 投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590835, encodeId=b01f59083538, content=请问一下,这是直接收泌尿外科相关文章的杂志吗<span class="quote">cweimed 2014-03-02 12:47:00 发表:<br>对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!</span>, beContent=cweimed 2014-03-02 12:47:00 发表: 对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590837, encodeId=291659083e9b, content=请问肾内科方向的可以投吗<span class="quote">cweimed 2014-03-02 12:47:00 发表:<br>对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!</span>, beContent=cweimed 2014-03-02 12:47:00 发表: 对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590836, encodeId=a16b590836c2, content=肾内科方向的可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2020-05-10 a pediatrics surgeon

    with editor10天了怎么回事?第六天还更新了下状态时间下但是状态没变,是换了编辑?

    4

    展开4条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1219534, encodeId=ef4712195345a, content=请问目前这个杂志需要版面费吗,投稿系统有这个板块, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d998163371, createdName=ms8000000627546001, createdTime=Sat May 14 10:42:17 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189708, encodeId=76e51189e084d, content=想问一下分子生物学实验的前列腺癌文章可以投稿么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44845159150, createdName=146b1ae0m26暂无昵称, createdTime=Wed Feb 02 14:32:40 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094379, encodeId=367010943e9c2, content=是否需要在讨论中说明文章局限性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094380, encodeId=42381094380c6, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590604, encodeId=a6fd59060405, content=with editor10天了怎么回事?第六天还更新了下状态时间下但是状态没变,是换了编辑?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573317, encodeId=b1cc5e3317e4, content=一个编辑直接拒,一个回了点comments,没啥建设性意见。都挺快的,review那个三个星期<span class="quote">yzu_mawenliang 2019-06-12 发表::<br>大概review了多久?审稿意见给了多少?</span><span class="quote">yzu_mawenliang 2019-06-12 00:00:00 发表:<br>大概review了多久?审稿意见给了多少?</span>, beContent=yzu_mawenliang 2019-06-12 发表:: 大概review了多久?审稿意见给了多少?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=384a2301707, createdName=acopolis, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583014, encodeId=d1d158301454, content=怎么样了<span class="quote">1550614717 2019-12-06 发表::<br>审稿时间:约2个月 投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。</span><span class="quote">1550614717 2019-12-06 22:14:00 发表:<br>投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。</span>, beContent=1550614717 2019-12-06 发表:: 审稿时间:约2个月 投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590835, encodeId=b01f59083538, content=请问一下,这是直接收泌尿外科相关文章的杂志吗<span class="quote">cweimed 2014-03-02 12:47:00 发表:<br>对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!</span>, beContent=cweimed 2014-03-02 12:47:00 发表: 对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590837, encodeId=291659083e9b, content=请问肾内科方向的可以投吗<span class="quote">cweimed 2014-03-02 12:47:00 发表:<br>对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!</span>, beContent=cweimed 2014-03-02 12:47:00 发表: 对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590836, encodeId=a16b590836c2, content=肾内科方向的可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2019-07-05 acopolis

    一个编辑直接拒,一个回了点comments,没啥建设性意见。都挺快的,review那个三个星期yzu_mawenliang 2019-06-12 发表::
    大概review了多久?审稿意见给了多少?
    yzu_mawenliang 2019-06-12 00:00:00 发表:
    大概review了多久?审稿意见给了多少?

    yzu_mawenliang 2019-06-12 发表:: 大概review了多久?审稿意见给了多少?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1219534, encodeId=ef4712195345a, content=请问目前这个杂志需要版面费吗,投稿系统有这个板块, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d998163371, createdName=ms8000000627546001, createdTime=Sat May 14 10:42:17 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189708, encodeId=76e51189e084d, content=想问一下分子生物学实验的前列腺癌文章可以投稿么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44845159150, createdName=146b1ae0m26暂无昵称, createdTime=Wed Feb 02 14:32:40 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094379, encodeId=367010943e9c2, content=是否需要在讨论中说明文章局限性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094380, encodeId=42381094380c6, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590604, encodeId=a6fd59060405, content=with editor10天了怎么回事?第六天还更新了下状态时间下但是状态没变,是换了编辑?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573317, encodeId=b1cc5e3317e4, content=一个编辑直接拒,一个回了点comments,没啥建设性意见。都挺快的,review那个三个星期<span class="quote">yzu_mawenliang 2019-06-12 发表::<br>大概review了多久?审稿意见给了多少?</span><span class="quote">yzu_mawenliang 2019-06-12 00:00:00 发表:<br>大概review了多久?审稿意见给了多少?</span>, beContent=yzu_mawenliang 2019-06-12 发表:: 大概review了多久?审稿意见给了多少?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=384a2301707, createdName=acopolis, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583014, encodeId=d1d158301454, content=怎么样了<span class="quote">1550614717 2019-12-06 发表::<br>审稿时间:约2个月 投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。</span><span class="quote">1550614717 2019-12-06 22:14:00 发表:<br>投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。</span>, beContent=1550614717 2019-12-06 发表:: 审稿时间:约2个月 投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590835, encodeId=b01f59083538, content=请问一下,这是直接收泌尿外科相关文章的杂志吗<span class="quote">cweimed 2014-03-02 12:47:00 发表:<br>对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!</span>, beContent=cweimed 2014-03-02 12:47:00 发表: 对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590837, encodeId=291659083e9b, content=请问肾内科方向的可以投吗<span class="quote">cweimed 2014-03-02 12:47:00 发表:<br>对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!</span>, beContent=cweimed 2014-03-02 12:47:00 发表: 对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590836, encodeId=a16b590836c2, content=肾内科方向的可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2020-01-10 a pediatrics surgeon

    怎么样了1550614717 2019-12-06 发表::
    审稿时间:约2个月 投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。
    1550614717 2019-12-06 22:14:00 发表:
    投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。

    1550614717 2019-12-06 发表:: 审稿时间:约2个月 投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1219534, encodeId=ef4712195345a, content=请问目前这个杂志需要版面费吗,投稿系统有这个板块, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d998163371, createdName=ms8000000627546001, createdTime=Sat May 14 10:42:17 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189708, encodeId=76e51189e084d, content=想问一下分子生物学实验的前列腺癌文章可以投稿么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44845159150, createdName=146b1ae0m26暂无昵称, createdTime=Wed Feb 02 14:32:40 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094379, encodeId=367010943e9c2, content=是否需要在讨论中说明文章局限性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094380, encodeId=42381094380c6, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590604, encodeId=a6fd59060405, content=with editor10天了怎么回事?第六天还更新了下状态时间下但是状态没变,是换了编辑?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573317, encodeId=b1cc5e3317e4, content=一个编辑直接拒,一个回了点comments,没啥建设性意见。都挺快的,review那个三个星期<span class="quote">yzu_mawenliang 2019-06-12 发表::<br>大概review了多久?审稿意见给了多少?</span><span class="quote">yzu_mawenliang 2019-06-12 00:00:00 发表:<br>大概review了多久?审稿意见给了多少?</span>, beContent=yzu_mawenliang 2019-06-12 发表:: 大概review了多久?审稿意见给了多少?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=384a2301707, createdName=acopolis, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583014, encodeId=d1d158301454, content=怎么样了<span class="quote">1550614717 2019-12-06 发表::<br>审稿时间:约2个月 投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。</span><span class="quote">1550614717 2019-12-06 22:14:00 发表:<br>投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。</span>, beContent=1550614717 2019-12-06 发表:: 审稿时间:约2个月 投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590835, encodeId=b01f59083538, content=请问一下,这是直接收泌尿外科相关文章的杂志吗<span class="quote">cweimed 2014-03-02 12:47:00 发表:<br>对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!</span>, beContent=cweimed 2014-03-02 12:47:00 发表: 对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590837, encodeId=291659083e9b, content=请问肾内科方向的可以投吗<span class="quote">cweimed 2014-03-02 12:47:00 发表:<br>对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!</span>, beContent=cweimed 2014-03-02 12:47:00 发表: 对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590836, encodeId=a16b590836c2, content=肾内科方向的可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2020-05-14 如梅

    请问一下,这是直接收泌尿外科相关文章的杂志吗cweimed 2014-03-02 12:47:00 发表:
    对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!

    cweimed 2014-03-02 12:47:00 发表: 对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1219534, encodeId=ef4712195345a, content=请问目前这个杂志需要版面费吗,投稿系统有这个板块, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d998163371, createdName=ms8000000627546001, createdTime=Sat May 14 10:42:17 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189708, encodeId=76e51189e084d, content=想问一下分子生物学实验的前列腺癌文章可以投稿么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44845159150, createdName=146b1ae0m26暂无昵称, createdTime=Wed Feb 02 14:32:40 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094379, encodeId=367010943e9c2, content=是否需要在讨论中说明文章局限性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094380, encodeId=42381094380c6, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590604, encodeId=a6fd59060405, content=with editor10天了怎么回事?第六天还更新了下状态时间下但是状态没变,是换了编辑?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573317, encodeId=b1cc5e3317e4, content=一个编辑直接拒,一个回了点comments,没啥建设性意见。都挺快的,review那个三个星期<span class="quote">yzu_mawenliang 2019-06-12 发表::<br>大概review了多久?审稿意见给了多少?</span><span class="quote">yzu_mawenliang 2019-06-12 00:00:00 发表:<br>大概review了多久?审稿意见给了多少?</span>, beContent=yzu_mawenliang 2019-06-12 发表:: 大概review了多久?审稿意见给了多少?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=384a2301707, createdName=acopolis, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583014, encodeId=d1d158301454, content=怎么样了<span class="quote">1550614717 2019-12-06 发表::<br>审稿时间:约2个月 投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。</span><span class="quote">1550614717 2019-12-06 22:14:00 发表:<br>投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。</span>, beContent=1550614717 2019-12-06 发表:: 审稿时间:约2个月 投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590835, encodeId=b01f59083538, content=请问一下,这是直接收泌尿外科相关文章的杂志吗<span class="quote">cweimed 2014-03-02 12:47:00 发表:<br>对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!</span>, beContent=cweimed 2014-03-02 12:47:00 发表: 对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590837, encodeId=291659083e9b, content=请问肾内科方向的可以投吗<span class="quote">cweimed 2014-03-02 12:47:00 发表:<br>对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!</span>, beContent=cweimed 2014-03-02 12:47:00 发表: 对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590836, encodeId=a16b590836c2, content=肾内科方向的可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2020-05-14 如梅

    请问肾内科方向的可以投吗cweimed 2014-03-02 12:47:00 发表:
    对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!

    cweimed 2014-03-02 12:47:00 发表: 对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1219534, encodeId=ef4712195345a, content=请问目前这个杂志需要版面费吗,投稿系统有这个板块, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d998163371, createdName=ms8000000627546001, createdTime=Sat May 14 10:42:17 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189708, encodeId=76e51189e084d, content=想问一下分子生物学实验的前列腺癌文章可以投稿么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44845159150, createdName=146b1ae0m26暂无昵称, createdTime=Wed Feb 02 14:32:40 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094379, encodeId=367010943e9c2, content=是否需要在讨论中说明文章局限性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094380, encodeId=42381094380c6, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590604, encodeId=a6fd59060405, content=with editor10天了怎么回事?第六天还更新了下状态时间下但是状态没变,是换了编辑?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573317, encodeId=b1cc5e3317e4, content=一个编辑直接拒,一个回了点comments,没啥建设性意见。都挺快的,review那个三个星期<span class="quote">yzu_mawenliang 2019-06-12 发表::<br>大概review了多久?审稿意见给了多少?</span><span class="quote">yzu_mawenliang 2019-06-12 00:00:00 发表:<br>大概review了多久?审稿意见给了多少?</span>, beContent=yzu_mawenliang 2019-06-12 发表:: 大概review了多久?审稿意见给了多少?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=384a2301707, createdName=acopolis, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583014, encodeId=d1d158301454, content=怎么样了<span class="quote">1550614717 2019-12-06 发表::<br>审稿时间:约2个月 投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。</span><span class="quote">1550614717 2019-12-06 22:14:00 发表:<br>投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。</span>, beContent=1550614717 2019-12-06 发表:: 审稿时间:约2个月 投过两篇,如果觉得不合适1般1周内会拒稿,直接显示decision in process。 第二篇under review1个月,现在到了decision in process 状态了,希望能有一个满意的结果。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590835, encodeId=b01f59083538, content=请问一下,这是直接收泌尿外科相关文章的杂志吗<span class="quote">cweimed 2014-03-02 12:47:00 发表:<br>对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!</span>, beContent=cweimed 2014-03-02 12:47:00 发表: 对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590837, encodeId=291659083e9b, content=请问肾内科方向的可以投吗<span class="quote">cweimed 2014-03-02 12:47:00 发表:<br>对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!</span>, beContent=cweimed 2014-03-02 12:47:00 发表: 对文章新意和深度都有较高要求,泌尿外科白金杂志,投稿后5天被拒,没有建设性意见,加油!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590836, encodeId=a16b590836c2, content=肾内科方向的可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2020-05-14 如梅

    肾内科方向的可以吗

    0

共52条页码: 1/6页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分